InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-25.5%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Kraus Al, Director. Officer active across 1 company, notably Cytosorbents Corp. In total, 4 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 31 August 2021. The latest transaction was filed on 6 February 2023 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations4 total
12,000 shares@ US$2.6544.2% of flowCommon StockSEC:0001104659-23-012103:0
5,000 shares@ US$1.9590.023% mcap25.0% of flowCommon StockSEC:0001104659-22-057514:0
Ideal exit: 31 Jan 2023 (T+270)
4,000 shares@ US$4.1250.035% mcap37.5% of flowCommon StockSEC:0001104659-21-112499:0
4,000 shares@ US$4.12520.9% of flowCommon StockSEC:0001104659-21-112499
4 of 4 declarations
About Kraus Al
Al Kraus is a Board Member at Cytosorbents Corp. He contributes to the governance of the company, bringing his expertise in strategy and business development. Kraus plays an important role in the strategic direction of Cytosorbents Corp.
